Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

First human implantation by North American surgeon of new spinal implant, SpineFrontier’s Arena-C HA, manufactured with innovative new material to enhance spinal fusion.
  • USA - English


News provided by

SpineFrontier, Inc.

Mar 17, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

A lateral fluoro of Arena-C HA, successfully implanted.
A lateral fluoro of Arena-C HA, successfully implanted.

...By incorporating hydroxyapatite (HA) into the PEEK Cage, fusion rates will improve...

Post this

(PRWEB) March 17, 2015 -- On March 11th, 2015, Dr. Jacob Rosenstein became the first surgeon in North America to implant Arena-C HA, an innovative spinal implant manufactured with PEEK-OPTIMA® HA Enhanced, a revolutionary new material that is utilized to enhance spinal fusion technology. This is the first time a device made with PEEK-OPTIMA® HA Enhanced has ever been implanted in a live human. He used this implant in an ACDF procedure to treat a patient suffering from spinal cord compression and myelopathy as a result of degenerative disc disease producing severe cervical stenosis. The procedure was completed at USMD Hospital in Arlington, TX

SpineFrontier’s Arena-C HA is an inter-vertebral spacer made from biocompatible plastic designed to provide mechanical stability for patients who need spine surgery. This was the first implant ever to be made with Invibio’s PEEK-OPTIMA® HA Enhanced, and was cleared by the FDA in October 2014. The material used in the implant incorporates hydroxyapatite, which is a naturally occurring compound in bony structures. The introduction of HA, which is fully integrated into the PEEK-OPTIMA Natural grade, provides a complete homogenous compound that ensures HA is present on all surfaces of a device. The implant, designed by SpineFrontier to provide mechanical stability for patients who need spine surgery, utilizes the revolutionary new biomaterial to enhance spinal fusion.

Dr. Jacob Rosenstein described the case: "The Arena-C HA PEEK-OPTIMA® cage is a potential game changer for interbody fusion devices. By incorporating hydroxyapatite (HA) into the PEEK Cage, fusion rates will improve as hydroxyapatite promotes osseointegration with direct bony in-growth into the cage, thus providing added stability and quicker healing. This is of great benefit to our patients who will heal faster and more predictably and return to normal activity sooner."

Dr. Rosenstein practices in Arlington, TX. He received his B.A. in Human Biology from Johns Hopkins University in 1976, where he was elected to the Phi Beta Kappa Society. He acquired his medical degree from the Johns Hopkins University School of Medicine in 1979. He was elected to the Alpha Omega Alpha Honor Medical Society there. In 1985, Dr. Rosenstein completed his residency and formal training in Neurological Surgery at U.T. Southwestern Medical Center/Parkland Hospital in Dallas, Texas. During his tenure he served as Chief Resident of Neurological Surgery. He undertook his Fellowship Training in Neurological Surgery at the Gough-Cooper Department of Neurology and Neurosurgery at the National Hospital for Nervous Diseases, London, England.

More about the Less Exposure Surgery Philosophy: To tailor treatment to the individual patient to have the quickest recovery and return to a pain-free lifestyle. If surgery is chosen, use Less Exposure Surgery techniques and technologies that lessen exposure proportionate to the problem and the patient, preserve unoffending anatomy, and utilize fundamental principles adapted to new technologies which are safe, easy to adopt, reproducible and lessen blood loss, surgical time, and exposure to radiation. The aim is to achieve maximal effectiveness for a rapid and less painful outpatient recovery.

To learn more about SpineFrontier visit http://www.spinefrontier.com. For more information about PEEK-OPTIMA HA Enhanced, please visit http://www.turbochargefusion.com.

About SpineFrontier Inc.
SpineFrontier Inc. (http://www.spinefrontier.com) is a growing medical device company that designs, develops and markets implants and instruments utilized for spine surgery. The SpineFrontier team focuses on developing innovative technologies and techniques for spinal surgery based on the Less Exposure Surgery (LES) philosophy. These technologies allow for same day outpatient surgery, due to minimal disruption of normal tissues. SpineFrontier believes LESS is more: LESS time in treatment and recovery is more time in action for our patients and surgeons. SpineFrontier is headquartered in Beverly, MA. It was founded in 2006, and released its first products in 2008. SpineFrontier is a KICVentures portfolio company and an exclusive manufacturer of LES technologies and instruments.

PEEK-OPTIMA® is a registered trademark of Invibio, Ltd. All rights reserved.

Anders Johnson, SpineFrontier, Inc., http://www.spinefrontier.com, +1 9782323990, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.